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Abstract
Objective—To examine the associations of bisphenol A (BPA) exposure with lung function
measures and exhaled nitric oxide (FeNO) in children.
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Study design—We performed a cross-sectional analysis of a subsample of US children age 6–
19 years who participated in the 2007–2010 National Health and Nutrition Examination Survey.
We assessed univariate and multivariable associations of urinary BPA concentration with the
predicted pulmonary function measures for age, sex, race/ethnicity and height (forced expiratory
function in 1 second – FEV1, forced vital capacity – FVC, forced expiratory flow 25–75% –
FEF2575, and FEV1/FVC) and with FeNO.
Results—Exposure and outcome data were available for 661 children. Median BPA was 2.4
ng/ml (IQR: 1.3, 4.1). In multivariable analysis a larger urinary BPA concentration was associated
with significantly decreased %FEF2575 (3.7%, 95% CI 1.0, 6.5) and %FEV1/FVC (0.8%, 95% CI
0.1, 1.7) but not %FEV1, %FVC, or FeNO. A child in the top quartile of BPA compared with the
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bottom quartile had a 10% decrease in %FEF2575 (95% CI −1, −19) and 3% decrease in
%FEV1/FVC (95% CI −1, −5).
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Conclusions—BPA exposure was associated with a modest decrease in %FEF2575 (small
airway function) and %FEV1/FVC (pulmonary obstruction) but not FEV1, FVC, or FeNO.
Explanations of the association cannot rule out the possibility of reverse causality.
Keywords
bisphenol A; BPA; cotinine; pulmonary function; asthma; exhaled nitric oxide
Asthma prevalence has risen dramatically over the past decades, and currently it affects
nearly one in ten children.(1, 2) Although many risk factors have been identified, the reason
for the rising prevalence remains poorly understood.(3, 4) It is possible that novel
environmental exposures may partially explain the rising prevalence.(5–8) Bisphenol A
(BPA) is a chemical used in the manufacture of some plastics and epoxy resins found in
many consumer products including the lining of canned foods. BPA exposure is pervasive,
largely via food; over 90% Americans have detectible BPA in their urine.(9)

NIH-PA Author Manuscript

Animal studies suggest that BPA may adversely affect lung development. Animal models
have identified an association of prenatal BPA exposure with the development of an
experimental model of asthma, and one study noted that rhesus macaques exposed to BPA
had accelerated development of secretory cells in the proximal airways.(10–12) However,
another animal study demonstrated that maternal exposure to BPA has only subtle effects on
allergic inflammation which did not lead to significant airway responsiveness.(13)
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Epidemiologic studies have suggested that BPA may contribute to the development of
asthma or bronchial obstruction in children.(14) The human studies note a similar
association of BPA and asthma, but the timing of exposure and associated risks are
conflicting. We previously reported that prenatal BPA exposure was associated with
increased odds of developing parent reported wheeze in young children.(15) However, one
study reported a postnatal association of BPA exposure with child asthma and wheeze but
did not find an association of prenatal BPA exposure.(14) Using 2005–2006 NHANES data,
Vaidya reported an association of urinary bisphenol A and allergic asthma primarily in
females.(16) Yet, no study has examined whether BPA exposure is associated with objective
measures of lung function such as spirometry, a tool used for diagnosing and monitoring
lung diseases.(17–19) This is a gap in knowledge because most asthma guidelines
recommend using spirometry and the measurement of forced expiratory volume in one
second (FEV1) for assessing respiratory status.(19) A newer measure, exhaled nitric oxide
(FeNO), has been proposed as potential noninvasive method to diagnose asthma and monitor
the response to anti-inflammatory therapy, yet no study has examined BPA exposure and its
relationship to FeNO.(20)
We therefore examined associations of urinary BPA with pulmonary function and FeNO in a
large, representative sample of US children, the 2007–2010 National Health and Nutrition
Examination Survey (NHANES).
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We analyzed a concatenated set of data for children ages 6–19 years who participated in the
2007–2010 NHANES, a nationally representative survey which includes demographic,
socioeconomic, and health questions and an examination component consisting of medical,
dental, and physiological measurements. The New York University School of Medicine
Institutional Review Board exempted this project from review on the basis of its analysis of
already collected and deidentified data.
BPA was measured in a spot urine specimen from a random, one-third subsample of
participants (n=1625) and analyzed with high-performance liquid chromatography and
tandem mass spectroscopy.(21) We substituted the limit of detection divided by √2 for BPA
concentrations below the limit of detection (3.3%). We log transformed BPA (natural log) to
account for skew and included urinary creatinine in all analyses to adjust for urinary
dilution.(9)
Measures of Respiratory Function and FeNO
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Spirometry procedures in 6–19 year olds followed American Thoracic Society (ATS)
standards.(22–24) Participants made forced vital capacity (FVC) maneuvers to meet
acceptability and reproducibility criteria. We focused our analyses on FEV1, FVC, forced
expiratory flow 25–75% (FEF2575), and FEV1/FVC because these measures are widely
used in clinical care. FEV1 is the most common measure of airway obstruction used for
asthma management, FVC is a widely-used measure of lung volume, and FEF2575 is a
measure of small airway function. Some investigators suggest that FEV1/FVC is a more
appropriate measure of obstruction in children than FEV1.(25–28) We calculated percent
predicted levels of each of these measurements (%FEV1, %FVC, %FEF2575, and %FEV1/
FVC) for age, sex, race/ethnicity, and height, using standard methods and used these
variables as our primary dependent variables.(29)
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Health technicians measured FeNO with the NIOX MINO® (Aerocrine AB, Solna, Sweden)
using an electrochemical sensor to detect exhaled nitric oxide levels (5 to 300 ppb).(30) Two
valid, reproducible measurements were required, following ATS guidelines.(20) ATS
recommends the use of cut-points rather than reference values for interpreting FeNO levels
and recommends different thresholds for children < 12 years old. We used the NHANES
variable average of two reproducible measurements, and we categorized children using the
cut-point of 36 ppb (children 6–11 years) or 39 ppb (children ≥12 years).(20, 31) FeNO
below the cut-point indicates less eosinophilic inflammation and good corticosteroid
response, whereas FeNO above the cut-point indicates inflammation and poor steroid
response.(20, 31)
Potential Confounders
Technicians collected data on height, weight, demographics, and medical history. Body
mass index (BMI) was calculated and BMI z-scores were derived from the Centers for
Disease Control and Prevention 2000 reference data.(32) We categorized overweight and
obese (≥1.036 and ≥1.64) using BMI z-score. We grouped race/ethnicity into Mexican
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American, other Hispanic, non-Hispanic White, and non-Hispanic Black. We categorized
caregiver education as: <9th grade, 9th–12th grade, high school/graduate equivalency
diploma, some college, ≥ college. We grouped the poverty-income ratio variable into
quartiles. We categorized age into 6–11 and 12–19 years, to emulate NHANES prevalence
reports. We included serum cotinine, a biomarker of tobacco exposure, as a covariate. We
categorized cotinine into low (<0.015 ng/mL), medium (<2 and ≥0.015 ng/mL) and high (≥2
ng/mL) categories.(33) We accounted for recent respiratory illness using response to, “in the
past 7 days, have you had a cough, cold, phlegm, runny nose or other respiratory illness? Do
not count allergies or hay fever.” We accounted for asthma diagnosis using response to, “has
a doctor or other health professional ever told [you] that [study participant has] asthma?”
We created “missing” categories for potential confounders (except BMI). Serum cotinine
was missing in 9.2%; otherwise, <5% of values were missing for other covariates.
Statistical analyses
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We calculated descriptive statistics for all demographic, exposure, and outcome data. We
accounted for the complex survey sampling design using standard techniques, using Stata
12.0 (College Station, TX).(34) We employed two-sided, tests for statistical significance
(defined as P≤0.05). We conducted linear regression analyses to examine the bivariate
association of BPA and potential covariates with each pulmonary function outcome
(%FEV1, %FVC, %FEF2575, and %FEV1/FVC) and logistic regression analysis to
examine the associations with FeNO. To assess robustness of the bivariate associations we
analyzed the association of BPA with pulmonary function using multivariable linear
regression, and we used multivariable logistic regression for FeNO associations. We used
the %FEV1 analysis to select covariates and applied the same covariates to each outcome.
Because BPA has estrogenic effects, we tested interactions of BPA with sex. We also
considered other biologically plausible covariate interactions including asthma diagnosis,
race, cotinine, and obesity. Lastly, we tested strength of the findings by reprising the
multivariable analysis of percent predicted lung function using Z-scores rather than %
predicted pulmonary outcome, and we also examined the final multivariable percent
predicted pulmonary outcome models without sample weights.
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We evaluated the specificity of associations of BPA and the respiratory outcomes by
examining the association of urinary concentrations of two other structurally similar
environmental phenols with the pulmonary outcomes. We evaluated benzophenone-3, a
chemical found in non-food consumer products, and triclosan, a chemical added to soaps
and other consumer products for antimicrobial function. Neither of these phenols is routinely
used in food packaging, an important source of BPA exposure, thus the routes of exposure to
these phenols have some differences from BPA.

Results
The analytic sample comprised 1625 participants with urinary BPA measurements out of the
5,096 children ages 6–19 who participated in NHANES for the study years. Out of the 1625
child participants with BPA samples, spirometry outcome data were available for 661. The
mean age was 13 years, 39% were overweight or obese, 52% were male, and 19% reported a
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doctor diagnosis of asthma (Table I). The geometric mean urinary BPA concentration was
2.5 ng/mL (95% CI 2.2, 2.8), the median BPA was 2.4 ng/ml (IQR: 1.3, 4.1). The mean
percent predicted FEV1 was 102 (Table II). The mean FeNO was 18.8 ppb, and 10.6% of
children were in the high FeNO category.
Bivariate Associations of Urinary BPA and Covariates with Respiratory Outcomes
Bivariate analyses failed to demonstrate association of BPA or any of the other potential
covariates (sex, race/ethnicity, poverty-income ratio, parent education, serum cotinine,
obesity, asthma diagnosis, recent respiratory infection, and age) with %FEV1 or %FVC
(Table III; available at www.jpeds.com).
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A larger BPA concentration was associated with decreased %FEV1/FVC (β=−0.01, 95% CI
−0.003, −0.018; Table III); a child with a BPA in the top quartile compared with the bottom
quartile had a 3% decrease in %FEV1/FVC (95% CI −1, −6). Similarly, a larger BPA
concentration was associated with decreased %FEF2575 (β=−0.03, 95% CI −0.001,
−0.057); a child with a BPA in the top quartile compared with the bottom quartile had an 8%
decrease in %FEF2575 (95% CI −2, −17). Asthma diagnosis was associated with decreased
%FEV1/FVC (β=−0.04, 95% CI −0.06, −0.03). Asthma diagnosis was also associated with a
decreased %FEF2575 (β=−0.12, 95% CI −0.19, −0.04), and having had a recent cold had a
borderline association with decreased %FEF2575 (β=−0.06, 95% CI −0.13, 0).
Although there was no bivariate association of BPA concentration with FeNO (OR=0.78,
95% CI 0.46, 1.3), having had a recent respiratory illness was associated with an increased
odds of having a high FeNO (OR=2.94, 95% CI 1.25, 6.67). There was no association of
BPA with asthma diagnosis, wheeze episode in the last year, or reported prescription of
asthma medication.
Multivariable Association of Urinary BPA with Pulmonary Outcomes
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In multivariable analysis, we found that urinary BPA concentration was associated with
%FEF2575 and %FEV1/FVC, but BPA was not associated with %FEV1, %FVC, or FeNO
(Tables IV and V). A log unit increase in BPA was associated with a 3.7% decrease in
%FEF2575 (95% CI 1.0, 6.5) and 0.9% decrease in %FEV1/FVC (95% CI 0.1, 1.7). A child
with a BPA in the top quartile compared with the bottom quartile had a 10% decrease in
%FEF2575 (95% CI 2, 19) and 3% decrease in %FEV1/FVC (95% CI 1, 5). Increased
urinary BPA concentration had a borderline association with a decrease in the log of FeNO
(β=−0.07, 95% CI −0.144, 0.008) when treated as a linear variable.
There was no statistically significant interaction of BPA concentration with sex for any of
the pulmonary function outcomes or FeNO (the strata did not differ by >10% and all
interaction terms were p>0.05). There was also no statistically significant interaction of BPA
with race, cotinine, obesity, or asthma diagnosis for any of the pulmonary function
outcomes.
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Sensitivity Analyses
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When we removed asthma diagnosis from the same multivariable analyses, the associations
were also similar: a larger urinary BPA concentration was associated with a decrease in
%FEF2575 and %FEV1/FVC (data not shown), but BPA was not associated with
differences in %FEV1, %FVC, or FeNO.
A multivariable analysis of Z-score outcomes failed to produce substantially different results
(data not shown). Unweighted analyses of urinary BPA with %FEF2575 demonstrated
similar results to the weighted analyses, but the relationships were attenuated. Urinary BPA
was associated with a 2.3% decrease in %FEF2575 (95% CI 0, 4.6) and a 0.3% decrease in
%FEV1/FVC (95% CI 0, 1.0). Additionally, the association of urinary BPA with FEV1
became significant; a log unit increase in BPA was associated with a 1.4% decrease in
%FEV1 (95% CI 0.2, 2.6).
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When we replaced BPA with the two different phenols (separately) in each of the models,
there was no association of benzophenone-3 or triclosan with any of the pulmonary function
outcomes or FeNO. We also added each of these phenols (separately) into multivariable
models with BPA in the model, and it did not change any of the associations. Triclosan was
measurable in 84% and benzophenone-3 was measurable in 99% of urine samples for the
661 participants.

Discussion
In a nationally representative sample, we found that BPA exposure was associated with a
modest decrease in two lung function measurements – %FEF2575 and %FEV1/FVC but not
%FEV1, %FVC, or FeNO. Although the associations we describe are modest, across a
population these changes may have important implications in long term lung function and
lung health. Lung capacity is maximal by the early 20s, so any reduction in pulmonary
function in childhood, even if not consistent with statistically significant obstructive or
restrictive disease, may confer a vulnerability to future lung disease.

NIH-PA Author Manuscript

There are several strengths and limitations to this study. First, even though the large
representative sample is a strength of this study, urinary BPA concentration and pulmonary
function data were not available for all participants which could limit the generalizability.
Second, due to the variability of urinary BPA concentrations over time, using a single
biomarker measure could result in exposure misclassification. Some investigators have
suggested that a single urinary BPA sample is predictive of long-term category of exposure,
but others have noted that BPA concentrations vary both within the day and between days.
(35, 36) The poor reproducibility of BPA could translate to non-differential misclassification
of exposure which likely would have biased the results towards the null. Third, the children
for whom all data were available were older, had higher cotinine levels, more had a recent
cold, and the mean BPA was higher compared with those for whom data was not available.
Although we accounted for these variables in the adjusted models, these differences may
decrease generalizability of the findings. Fourth, the analysis was cross-sectional and cannot
establish causality. However, the association may suggest a possible mechanism of BPA
effect – obstruction of small airways. Moreover, the lack of association of either of the other
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phenols (triclosan and benzophenone-3) with pulmonary function adds weight to the BPA
association. Fifth, reverse causality is a possibility in this analysis; however, the most
common BPA exposure route is food, and reverse causality would imply that children with
decreased pulmonary function are more likely to eat more BPA containing foods, which
seems unlikely.
Spirometry is a frequently used tool for diagnosing and monitoring lung disease in children.
(17–19) Most asthma guidelines recommend using spirometry and the measure of forced
expiratory volume in one second (FEV1), a measure of airway obstruction, for assessing
respiratory status.(19) However, some have suggested that it might be more appropriate to
use FEV1/FVC (another measure of airway obstruction) or FEF2575 (a measure of small
airway function) to assess asthma severity in children.(25, 26) It has been suggested that
FEF2575 may be a more sensitive marker of small airway obstruction than FEV1.(27, 28)
Our finding of an association of BPA with %FEF2575 and %FEV1/FVC may suggest that
the BPA is associated with small airway obstruction rather than a child’s overall lung
volume (FVC). Future studies will be needed to confirm mechanistic associations.
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Animal models have identified an association of prenatal BPA exposure with the
development of an experimental model of asthma, and one study noted that rhesus macaques
exposed to BPA had accelerated development of secretory cells in the proximal airways.
(10–12) However, another animal study demonstrated that maternal exposure to BPA has
only subtle effects on allergic inflammation which did not lead to significant airway
responsiveness.(13) The human studies note a similar association of BPA and asthma, but
the timing of exposure and associated risks are conflicting. We previously noted an
association of prenatal urinary BPA and wheeze in young children.(15) However, a more
recent study reported a postnatal association of BPA exposure with child asthma and wheeze
but did not find an association of prenatal BPA exposure.(14) Using 2005–2006 NHANES
data, Vaidya reported an association of urinary bisphenol A and allergic asthma primarily in
females.(16) We did not find an association of urinary BPA concentration with asthma
diagnosis in children in this analysis. When we removed asthma from our adjusted model, it
did not affect the BPA and pulmonary function association suggesting that the associations
are independent of any effects of asthma diagnosis. The association that we found may
reflect the timing of exposure that was available (concurrent BPA levels), and we cannot
comment on any windows of vulnerability or effects of prenatal BPA exposure.
Our finding of a lack of association of BPA with FeNO levels is contrary to the findings
from Donohue et al.(14) In their study, Donohue et al noted that at age 7 years of age BPA
was associated with FeNO collected between age 7 and 11 years. There are several
dissimilarities between that study and this NHANES analysis, which could account for this
difference: (1) the collection method they used was an offline device and NHANES was
online; (2) they analyzed FeNO as a linear variable only; (3) their BPA levels may have
been collected at different ages than the FeNO measurement; and (4) their cohort was
primarily African American and Dominican. The lack of an association of BPA with FeNO
may suggest that the mechanism for the BPA and pulmonary function association may be
via a pathway other than eosinophilic inflammation; this should be evaluated in future
mechanistic studies.
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In summary, we found that urinary BPA concentration was associated with a decrease in two
key lung function measurements in children – %FEF2575 and %FEV1/FVC but not
%FEV1, %FVC, or FeNO. While the analysis was cross-sectional and cannot establish
causality, it suggests a possible mechanism of BPA effect (obstruction of small airways),
which merits additional evaluation. Moreover, these decrements in pulmonary function
projected across a population may have important implications in long term lung function
and lung health.
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ATS

American Thoracic Society

BPA

Bisphenol A

FEV1

Forced Expiratory Volume in one second

FEV1/FVC

Forced Expiratory Volume in one second divided by Forced Vital
Capacity

FEF2575

Forced Expiratory Flow 25–75%

FVC

Forced Vital Capacity

FeNO

Fraction of Exhaled Nitric Oxide

NHANES

National Health and Nutrition Examination Survey

%FEV1

Percent Predicted FEV1

%FEV1/FVC

Percent Predicted FEV1/FVC

%FEF2575

Percent Predicted FEF2575

%FVC

Percent Predicted FVC
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Study Population Characteristics and Exposures for the Children with BPA levels (n=1625).
Spirometry Data
Available
N=661
N (Weighted %)

Spirometry Data
Not Available
Weighted
N=964
N (Weighted %)

345 (51.6)

501 (50.9)

Hispanic-Mexican

178 (13.4)

250 (14.6)

Hispanic-Other Hispanic

93 (6.8)

123 (9.4)

Non-Hispanic White

197 (64.6)

293 (60.5)

Non-Hispanic Black

193 (15.2)

207 (15.5)

1st quartile (< 0.83)

140 (16.5)

250 (15.4)

2nd quartile (0.83 to 1.59)

137 (14.5)

123 (20.0)

3rd

quartile (1.60 to 3.09)

190 (28.5)

293 (21.0)

quartile (at least 3.1)

150 (36.5)

207 (34.7)

44 (4.0)

91 (8.9)

69 (8.7)

112 (7.9)

127 (12.5)

177 (13.5)

146 (20.0)

226 (21.4)

Male sex

p-value
Comparing
Weighted
Percentages
or Means
NS

Race/ethnicity

NS

Poverty-income ratio

NIH-PA Author Manuscript

4th

Missing

0.04

Parent/caregiver education
Less than 9th grade
9th–12th

grade

High school or GED
Some college

191 (30.5)

257 (28.7)

College or greater

102 (24.9)

164 (25.7)

Missing

26 (3.4)

28 (2.8)

< 0.015

101 (14.3)

200 (21.0)

0.015–1.9

397 (59.2)

524 (52.6)

≥ 2.0

90 (17.3)

106 (12.1)

Missing

73 (9.2)

134 (14.3)

Not overweight

406 (65.6)

576 (64.0)

Overweight

96 (13.6)

173 (17.8)

Obese

159 (20.8)

200 (18.2)

Doctor diagnosed asthma

125 (18.3)

183 (17.9)

Respiratory illness in last week

131 (20.8)

25 (2.4)

NS

Serum cotinine (ng/mL)

0.01

Weight category
NS

NIH-PA Author Manuscript

NS
0.001

Age (years), mean (SD)

13.0 (5.4)

12.4 (7.6)

0.02

BPA (ng/mL), geometric mean (95% CI)

2.5 (2.2, 2.8)

2.0 (1.9, 2.2)

0.009

NS = Not significant (<0.05)
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Mean of the Percent Predicted Pulmonary Function or FeNO for the Study Population
Mean

25th Percentile

75th Percentile

FEV1

102

92

110

FVC

103

94

111

FEF25–75

99

80

115

FEV1/FVC

98

94

102

FeNO (ppb)

12.0

8.0

20.5

NIH-PA Author Manuscript
NIH-PA Author Manuscript
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0.007
−0.008

Non-Hispanic White

Non-Hispanic Black

quartile (1.60 to 3.09)

3rd

Missing
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−0.075, 0.063
−0.086, 0.085

−0.012
−0.006
−0.00

Some college

College or greater

≥ 2.0

Missing

Not overweight

Ref.

0.011
−0.006

0.015–1.9

Weight category

Ref.
0.036

< 0.015

Serum cotinine (ng/mL)

Missing

−0.0866, 0.063

0.010
−0.017

grade

High school or GED

Ref.

−0.006, 0.019

−0.029, 0.051

0.003, 0.068

Ref.

−0.086, 0.105
−0.089, 0.055

Ref.

9th–12th

Ref.

−0.083, 0.021

−0.031

Less than 9th grade

Parent/caregiver education

−0.032, 0.05

−0.012, 0.061

−0.006, 0.075

Ref.

−0.049, 0.034

−0.017, 0.031

−0.119, −0.026

Ref.

−0.014, 0.02

95% CI

0.009

0.025

0.035

quartile (0.83 to 1.59)

2nd

4th quartile (at least 3.1)

Ref.

1st quartile (< 0.83)

Poverty-income ratio

−0.073

Ref.

0.003

Hispanic-Other Hispanic

Hispanic-Mexican

Race/ethnicity

Male sex

β

%FEV1

Ref.

−0.039

0.011

0.023

Ref.

0.012

−0.019

−0.038

−0.026

0.004

Ref.

−0.013

0.001

0.034

0.043

Ref.

−0.0004

0.006

−0.044

Ref.

0.019

β

Ref.

−0.081, 0.003

−0.038, 0.059

−0.015, 0.061

Ref.

−0.08, 0.103

−0.084, 0.046

−0.109, 0.034

−0.098, 0.045

−0.071, 0.078

Ref.

−0.07, 0.044

−0.043, 0.044

−0.003, 0.071

0.006, 0.079

Ref.

−0.032, 0.032

−0.035, 0.023

−0.078, −0.01

Ref.

−0.002, 0.04

95% CI

%FVC

Ref.

0.018

−0.0004

0.012

Ref.

−0.009

0.015

0.023

0.013

0.005

Ref.

−0.017

0.006

−0.006

−0.011

Ref.

−0.018

0.012

−0.031

Ref.

−0.004

β

Ref.

−0.008, 0.044

−0.024, 0.023

−0.002, 0.027

Ref.

−0.048, 0.03

0.001, 0.029

0.004, 0.042

−0.003, 0.029

−0.026, 0.035

Ref.

−0.044, 0.011

−0.018, 0.03

−0.03, 0.018

−0.031, 0.01

Ref.

−0.036, 0.001

−0.007, 0.03

−0.053, −0.008

Ref.

−0.016, 0.008

95% CI

%FEV1/FVC

Ref.

0.088

−0.021

0.045

Ref.

−0.034

0.039

0.057

0.006

0.028

Ref.

−0.083

0.037

−0.001

0.017

Ref.

−0.033

0.058

−0.113

Ref.

−0.008

β

Ref.

−0.11, 0.128

−0.103, 0.061

−0.036, 0.125

Ref.

−0.153, 0.084

−0.073, 0.151

−0.035, 0.149

−0.088, 0.1

−0.128, 0.185

Ref.

−0.176, 0.011

−0.058, 0.131

−0.088, 0.086

−0.057, 0.091

Ref.

−0.111, 0.046

−0.006, 0.123

−0.199, −0.027

Ref.

−0.051, 0.035

95% CI

%FEF2575

Unadjusted Association of the Participant Characteristics and Exposures with Pulmonary Function and FeNO (n=661).

Ref.

0.83

0.82

0.64

Ref.

0.61

1.37

0.47

1.18

2.70

Ref.

0.48

1.0

1.33

1.09

Ref.

1.96

0.74

0.61

Ref.

0.69

Odds
Ratio

Ref.

0.14, 4.76

0.22, 3.03

0.20, 2.08

Ref.

0.13, 3.03

0.31, 6.25

0.09, 2.44

0.32, 4.35

0.68, 11.11

Ref.

0.08, 2.86

0.45, 2.22

0.51, 3.57

0.38, 3.13

Ref.

0.92, 4.35

0.36, 1.52

0.17, 2.17

Ref.

0.29, 1.64

95% CI

FeNO*
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0.013
−0.021
−0.005

Quartile 2

Quartile 3

Quartile 4

Ref.

Quartile 1

−0.056, 0.046

−0.066, 0.023

−0.027, 0.054

Ref.

0.024

0.011

0.018

Ref.

0.004

0.002

−0.012

0.027

0.033

0.038

β

−0.03, 0.077

−0.037, 0.06

−0.029, 0.066

Ref.

−0.015, 0.022

−0.003, 0.006

−0.054, 0.031

−0.004, 0.058

0.006, 0.061

0.003, 0.074

95% CI

−0.034

−0.036

−0.007

Ref.

−0.010

0.002

−0.011

−0.043

−0.017

−0.016

β

−0.058, −0.010

−0.064, −0.009

−0.033, 0.019

Ref.

−0.018

0, 0.003

−0.033, 0.011

−0.061, −0.025

−0.046, 0.012

−0.043, 0.01

95% CI

−0.075

−0.072

0.008

Ref.

−0.029

−0.005

−0.062

−0.116

−0.014

0.007

β

−0.171, 0.021

−0.171, 0.027

−0.079, 0.096

Ref.

−0.057, −0.001

−0.012, 0.001

−0.126, 0.003

−0.191, −0.04

−0.14, 0.111

−0.102, 0.117

95% CI

%FEF2575

0.72

0.5

1.61

Ref.

0.78

1.04

2.94

1.67

1.06

1.59

Odds
Ratio

This column represents the logistic regression model of being in the high FeNO category (i.e. an odds ratio over 1.0 suggests an increased odds of having high FeNO).

*

−0.004, 0.005

0.0004
−0.006

Age (years), mean (SD)

BPA (ng/mL), geometric mean (95% CI)

BPA (ng/mL),

−0.062, 0.016
−0.057, 0.011

−0.023
−0.023

Doctor Diagnosed Asthma

Respiratory Illness in last week

−0.025, 0.013

−0.023, 0.061

0.019

−0.024, 0.074

0.025

95% CI

Obese

NIH-PA Author Manuscript

Overweight

β

%FEV1/FVC

NIH-PA Author Manuscript
%FVC

0.18, 2.92

0.14, 1.73

0.56, 4.59

Ref

0.46, 1.3

0.98, 1.12

1.25, 6.67

0.63, 4.55

0.28, 4.17

0.54, 4.55

95% CI

FeNO*

NIH-PA Author Manuscript
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−0.055, 0.028

−0.004, 0.048

−0.017, 0.017

95% CI

−0.013

−0.043

−0.009

β

−0.032, 0.007

−0.062, −0.023

−0.017, −0.001

95% CI

%FEV1/FVC

Adjusted for urinary creatinine, body mass index, age, poverty-income ratio, sex, race, and serum cotinine.

−0.014

0.022

0.0001

β

%FVC

−0.058

−0.114

−0.037

β

−0.126, 0.009

−0.190, −0.037

−0.065, −0.010

95% CI

%FEF2575

3.15

2.28

0.72

Odds
Ratio

1.36, 7.28

0.80, 6.54

0.40, 1.28

95% CI

FeNO†

This column represents the logistic regression model of being in the high FeNO category (ie, an odds ratio over 1.0 suggests an increased odds of having high FeNO).

†

*

−0.061, 0.009

−0.026
−0.025

Doctor Diagnosed Asthma

Respiratory Illness In the last week

−0.062, 0.012

−0.027, 0.007

95% CI

−0.010

BPA (ng/mL)

β

%FEV1

Adjusted Associations* of linear BPA, asthma diagnosis, and recent respiratory illness with pulmonary function and FeNO (n=661)
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−0.062, 0.009

0.013

−0.014

0.021

0.015

−0.055, 0.027

−0.004, 0.047

−0.035, 0.066

−0.032, 0.058

−0.015, 0.062

Ref.

95% CI

−0.014

−0.043

−0.030

−0.038

−0.008

Ref.

β

−0.033, 0.005

−0.063, −0.023

−0.053, −0.006

−0.063, −0.013

−0.030, 0.013

Ref.

95% CI

%FEV1/FVC

Adjusted for urinary creatinine, body mass index, age, poverty-income ratio, sex, race, and serum cotinine.

−0.063, 0.011

−0.027
−0.026

Doctor Diagnosed Asthma

Respiratory Illness In the last week

−0.061, 0.006
−0.060, 0.029

−0.027
−0.016

0.024

Ref.

β

%FVC

−0.061

−0.115

−0.103

−0.106

−0.010

Ref.

β

−0.130, 0.008

−0.193, −0.038

−0.191, −0.015

−0.193, −0.020

−0.097, 0.077

Ref.

95% CI

%FEF2575

2.23

3.13

0.59

0.47

1.33

Ref.

Odds
Ratio

0.74, 6.75

1.35, 7.29

0.12, 2.94

0.11, 1.98

0.32, 5.48

Ref.

95% CI

FeNO†

This column represents the logistic regression model of being in the high FeNO category (ie, an odds ratio over 1.0 suggests an increased odds of having high FeNO).

†

*

Ref.
−0.023, 0.048

Quartile 3

Quartile 2

95% CI

Quartile 4

Ref.
0.013

Quartile 1

BPA (ng/mL)

β

%FEV1

Adjusted Associations* of linear BPA in quartiles, asthma diagnosis, and recent respiratory illness with pulmonary function and FeNO (n=661)
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